Fetal and Neonatal Monitoring Market Analysis & Forecast: 2026-2033

Fetal and Neonatal Monitoring Market Size and Share Analysis- 2026 To 2033

The Fetal and Neonatal Monitoring Market size is anticipated to grow at a CAGR of 7.5% with USD 11.6 Bn in 2026 and is expected to reach USD 19.2 Bn in 2033. The primary drivers for the Fetal and Neonatal Monitoring Market are predominantly linked to the increasing prevalence of high-risk pregnancies, preterm births, and maternal-fetal complications. Additional factors include growing awareness of neonatal health, rising demand for continuous and remote monitoring solutions, and adoption of advanced technologies such as wireless and wearable fetal monitors. According to the National Library of Medicine, approximately 15 million babies are born preterm every year, highlighting the urgent need for enhanced fetal and neonatal monitoring solutions.

Key Takeaways

• The fetal monitoring devices segment is likely to dominate the market with 59.2% in 2026. The segment’s growth is owing to the increasing awareness of prenatal health, rising high-risk pregnancies, and adoption of continuous fetal monitoring in hospitals. Fetal heart rate monitoring is performed in nearly 90% of labors to evaluate the baby’s neurological well-being.
• The non-portable monitoring devices segment is set to lead with 58.5% in 2026. The segment’s growth is owing to hospital-based monitoring preference, integration with EMR systems, and higher reliability of fixed bedside devices in intensive care and maternity wards.
• The non-invasive monitoring devices segment is set to lead with 70.5% in 2026. The segment’s growth is owing to the safety, patient comfort, and widespread adoption of non-invasive techniques like Doppler ultrasound and cardiotocography. A labor heart-rate study found non-invasive fECG to be more accurate than ultrasound, with a lower error rate of 4.8 BPM versus 14.3 BPM.
• The hospitals segment is set to lead with 62% in 2026. The segment’s growth is owing to the presence of specialized neonatal units, growing institutional deliveries, and adoption of advanced maternal-fetal monitoring solutions.
• North America is expected to acquire the prominent share of 38.9% in 2026. The region’s growth is owing to the high healthcare expenditure, advanced hospital infrastructure, strong insurance coverage for maternal and neonatal care, and increasing R&D in fetal monitoring technologies. FDA-cleared wireless patches, such as GE Healthcare's Novii+, are reported comfortable by 65.6% of pregnant women, with 96.9% considering them useful or very useful in hospital settings.

Segmental Insights 

To learn more about this report, Request Free Sample

Why is Fetal Monitoring Devices Acquiring the Largest Share?

On the basis of product type, the fetal monitoring devices segment is projected to account for the largest Fetal and Neonatal Monitoring Market share of 59.2% in 2026. The segment’s growth is owing to its essential role in continuously and accurately assessing fetal vital signs, which are crucial for clinical decision‑making during high‑risk pregnancies and labor.

This demand is also heightened by the regulatory emphasis on reliable monitoring tools. In September 2025, the U.S. Food and Drug Administration (FDA) issued a safety communication cautioning against using unauthorized infant monitoring devices for vital signs owing to the dangers of inaccurate measurements, thereby reinforcing the reliance on cleared clinical fetal monitors.

The clinical urgency for effective fetal monitoring is underscored by the government data showing that preterm birth affects about one in ten infants in the U.S. and that over 21,000 stillbirths occur annually. This is driving hospitals and clinics to adopt cutting edge monitoring technologies to support early intervention.

In October 2025, the University of Maryland Medical System launched NEST, a remote fetal monitoring center on the East Coast. The center uses AI technology and 17 specialized nurses to provide real-time oversight of fetal heart rates and identify patients needing urgent attention.

Non-invasive Monitoring Devices hold the Largest Market Share 

To learn more about this report, Request Free Sample

On the basis of method, the non-invasive monitoring devices segment lead with a major 70.5% share in 2026. The segment’s growth is owing to their ability to deliver accurate, continuous fetal assessment without requiring invasive procedures, which enhances patient safety and comfort.

Multi-center validation studies reported on PubMed Central indicate that advanced non-invasive fetal electrocardiography (NIFECG) devices maintain 0% signal loss regardless of maternal Body Mass Index (BMI), addressing a key limitation of traditional continuous cardiotocography (cCTG) in high-BMI patients.

In addition, the feasibility studies conducted by the public health hospital networks show that multimodal non-invasive systems combining electrocardiography and phonocardiography achieve a 74% to 84% direct correlation with reference continuous ultrasound outputs, thereby ensuring clinical reliability without invasive scalp attachments.

In February 2024, GE HealthCare received FDA 510(k) clearance for the Novii+ Wireless Maternal and Fetal Monitoring Solution, indicated for pregnant patients ≥34 weeks. The device noninvasively monitors fetal heart rate, maternal heart rate, and uterine activity while also allowing for mobility and comfort during labor.

Market Drivers

Shift to Wearable and Wireless Devices is Transforming the Fetal and Neonatal Monitoring Market in the US

In the United States, the shift to wearable and wireless devices is transforming the fetal and neonatal monitoring market by enabling continuous, patient‑centric care that moves beyond traditional wired systems and intermittent hospital‑based checks. Innovations in wireless and wearable technologies like patch‑based and sensor‑enabled platforms are increasing patient mobility and comfort while delivering real‑time maternal and fetal health data to clinicians, fueling broader adoption in both prenatal and delivery settings.

Government‑sponsored programs such as the NIH’s RADx® Tech for Maternal Health Challenge have also accelerated the development of novel monitoring solutions by awarding funding to teams working on wearable, smartphone‑integrated, and point‑of‑care technologies that can shorten time‑to‑market.

In April 2026, Sibel Health received FDA 510(k) clearance for ANNE Maternal, the world’s first fully wireless, comprehensive maternal-fetal monitoring platform. It enables continuous monitoring of maternal and fetal health using advanced wearable sensors combined with integrated clinical decision support.

AI ‑driven Non ‑invasive Fetal EEG Monitoring Platforms: A Major Breakthrough in the Fetal and Neonatal Monitoring Market

AI-driven non-invasive fetal EEG monitoring is transforming the maternal-fetal medicine by tracking fetal brain activity through the maternal abdomen using wearable sensors and deep learning to isolate signals from noise. This technology, led by the firms like Wavelet Medical and validated in clinical pilots at institutions like Yale, aims to minimize unnecessary C-sections, prevent brain injuries, as well as lower the costs.

In April 2026, Wavelet Medical teamed up with Aegis Ventures to launch the first non invasive AI-powered fetal EEG monitoring platform. It is specifically designed to detect fetal distress in real time and improve maternal-fetal outcomes while also reducing unnecessary C-sections. The device is being piloted at three clinical sites, with plans to expand trials in additional hospitals in the U.S.

Current Events and Their Impact on the Fetal and Neonatal Monitoring Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Fetal and Neonatal Monitoring Market Trends

• The rising adoption of advanced fetal and neonatal monitoring systems is enhancing the early detection of complications, improving neonatal outcomes, and supporting timely interventions in high-risk pregnancies.
• The integration of wireless, non-invasive, and portable monitoring devices is allowing for continual monitoring, facilitating real-time decision-making and personalized perinatal care, thereby improving the patient safety as well as clinical efficiency worldwide.
• AI-enabled predictive analytics and smart monitoring platforms is allowing for proactive management of fetal distress, preterm labor, and neonatal respiratory challenges, thereby supporting better long-term developmental outcomes.
• The global preterm births remain high, with an estimated 13.4 million babies born before 37 weeks of gestation, over 1 in 10 live births worldwide, thereby making cutting edge monitoring crucial for early detection and intervention.
• Neonatal mortality remains a critical concern. In 2024, about 2.3 million newborns died within the first 28 days of life, accounting for 47% of all under, thereby emphasizing the need for quality fetal along with neonatal monitoring care.
• Supportive healthcare policies and insurance coverage are expanding the access to perinatal monitoring. In the U.S., approximately 10.41% of live births were preterm and 8.58% were low birth weight, thereby highlighting the ongoing perinatal health challenges requiring effective monitoring practices.

Regional Insights 

To learn more about this report, Request Free Sample

North America Dominates Owing to the Increased Focus on Maternal and Neonatal Safety

The North America region accounts for 38.9% of the market share in 2026. The region’s growth is owing to a combination of advanced hospital infrastructure, high adoption of digital health technologies, and increased focus on maternal and neonatal safety.

According to the U.S. National Vital Statistics System, the provisional fetal mortality rate declined 2% in 2024 to 5.41 fetal deaths per 1,000 live births and fetal deaths, thereby underscoring the continual demand for the comprehensive monitoring in high

In October 2025, Lee Health launched Florida’s first AI-powered birth care center, a remote fetal monitoring hub that provides real-time data to support clinicians. The system enables continuous 24/7 monitoring of mothers and babies, enhancing safety and improving outcomes.

Asia Pacific Fetal and Neonatal Monitoring Market Trends

Asia Pacific is expected to witness strong growth in Fetal and Neonatal Monitoring Market over the forecast period. The region’s growth is owing to the rising high-risk births, stronger public maternity programs, and wider hospital investment in connected fetal and newborn surveillance.

UNICEF reported that Southern Asia accounted for 34% of global neonatal deaths in 2022, reinforcing demand for fetal heart-rate monitors, CTG systems, pulse oximetry, incubator monitoring, and remote neonatal observation tools.

In October 2025, Owlet received CDSCO approval for its Dream Sock device, marking its entry into India’s digital health market. The company plans to launch its integrated infant monitoring suite, including Dream Sock, Dream Sight, and Dream Duo, across India in early 2026.

Rising Perinatal Risk and AI-enabled Bedside Monitoring are Accelerating the Fetal and Neonatal Monitoring Market in United States

The United States Fetal and Neonatal Monitoring Market is experiencing growth. This is owing to the rising need for continuous fetal surveillance, early neonatal risk detection, and rapid monitoring in labor rooms and NICU settings. In 2023, the U.S. perinatal mortality rate was 8.36 per 1,000 live births and fetal deaths, thereby underscoring continual clinical demand for cutting edge monitoring in labor as well as NICU settings.

In November 2025, Ceribell received the FDA 510(k) clearance for its Clarity algorithm. This makes it the first AI-powered EEG system to detect seizures in patients from pre-term neonates through adults. The system enables rapid bedside detection, diagnosis, and treatment of non-convulsive seizures.

China Fetal and Neonatal Monitoring Market Trends

China’s Fetal and Neonatal Monitoring Market is driven by a strong maternal-child health infrastructure, rising hospital delivery reliance, and demand for early identification of fetal distress, neonatal deterioration, and high-risk pregnancy complications. The National Health Commission reported that China’s infant mortality rate fell to 4 per 1,000 in 2024, a record low, supporting continued investment in clinically reliable fetal heart rate, cardiotocography, neonatal vital-sign, and NICU monitoring systems.

A recent regulatory development also supports device availability. In June 2025, China’s NMPA listed approval-delivery information for a fetal monitor under acceptance number JQX2401480, indicating ongoing market-entry activity for monitoring equipment.

Who are the Major Companies in Fetal and Neonatal Monitoring Industry

Some of the major key players in Fetal and Neonatal Monitoring Market are Becton, Dickinson and Company, Fujifilm SonoSite Inc., Medtronic Plc, Dragerwerk AG & Co. KGAA, Cooper Surgical, Getinge AB, Natus Medical Incorporated, GE Healthcare, Siemens Healthcare GmbH, ArjoHuntleigh, Inc., Neoventa Medical, Koninklijke Philips N.V., Analogic Corporation, Spacelabs Healthcare Inc., Smiths Medical, and Masimo.

Key News

• In May 2026, Momcozy launched the BM08, the first contact-free baby monitor that uses millimeter-wave radar to track infants’ breathing and heart dynamics in real time. The device requires no wearables, sensor pads, or physical contact, and is available for $249.99.
• In February 2026, GE HealthCare joined hands with Diagnoly to integrate its AI-driven Fetoly solution in Voluson ultrasound systems. This collaboration is enhancing the fetal ultrasound assessments by providing real-time AI analysis of fetal brain and cardiac development for clinicians in the U.S. as well as Europe.
• In June 2025, GE HealthCare teamed up with Raydiant Oximetry to co-develop fetal oxygen saturation monitoring technology. The collaboration aims to integrate Raydiant’s pulse oximetry into GE’s fetal monitoring platforms, providing real-time insights to improve detection of fetal distress and support clinical decision-making during labor.

Market Report Scope 

Analyst Opinion

• Fetal and neonatal monitoring is driven by the critical healthcare needs. Globally, approximately 140 million babies are born each year, and timely monitoring can prevent complications, lowering neonatal mortality, which accounts for roughly 47% of under 5 deaths worldwide. This indicates that the market growth is driven by urgent clinical need rather than trends alone.
• The continual electronic fetal monitoring (EFM) and advanced neonatal intensive care unit (NICU) monitoring are being adopted at a rapid pace. The estimates show that over 80% of high-risk deliveries now involve continuous fetal or neonatal monitoring in developed countries, thereby highlighting the widespread clinical reliance.
• Technological innovations like wireless, non-invasive fetal monitors and integrated NICU systems are gaining traction. The clinical studies indicate that non-invasive fetal monitoring can detect distress with over 95% accuracy, while modern NICU devices improve early intervention, patient outcomes, and clinician efficiency. This is encouraging the adoption across both emerging as well as mature healthcare markets.

Market Segmentation

• By Product Type (Revenue, USD Bn, 2021-2033)
  • Fetal Monitoring Devices
    • Heart Rate Monitors
    • Uterine Contraction Monitor
    • Pulse Oximeters
    • Others (Fetal ECG, Doppler, and Continuous Monitors)
  • Neonatal Monitoring Devices
    • Cardiac Monitors
    • Capnographs
    • Blood Pressure Monitors
    • Pulse Oximeters
    • Others (X-ray, CT scans, and MRI)
• By Portability (Revenue, USD Bn, 2021-2033)
  • Portable Monitoring Devices
  • Non-portable Monitoring Devices
• By Method (Revenue, USD Bn, 2021-2033)
  • Invasive Monitoring Devices
  • Non-invasive Monitoring Devices
• By End User (Revenue, USD Bn, 2021-2033)
  • Hospitals
  • Nursing Homes
  • Specialty Clinics
  • Ambulatory Surgery Centers
• By Region (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa

Sources

Primary Research Interviews

• Fetal and Neonatal Monitoring Device Manufacturers
• Neonatologists and Pediatric Specialists
• Obstetricians and Gynecologists
• NICU and Maternity Ward Administrators
• Hospital Procurement Managers
• Biomedical Engineers and Clinical Technology Consultants
• Others

Databases

• Bloomberg Terminal
• Thomson Reuters Eikon
• IQVIA
• Others

Magazines

• Medical Device Network
• MedTech Dive
• Healthcare IT News
• Neonatal Intensive Care Magazine
• HealthTech Magazine
• Others

Journals

• Journal of Perinatology
• American Journal of Obstetrics and Gynecology
• Pediatrics Journal
• JAMA Pediatrics
• The Lancet Child & Adolescent Health
• Obstetrics & Gynecology Journal
• Others

Newspapers

• Financial Times
• The Wall Street Journal
• Reuters
• Bloomberg News
• The Economic Times
• Others

Associations

• World Health Organization (WHO)
• American Academy of Pediatrics (AAP)
• American College of Obstetricians and Gynecologists (ACOG)
• European Society for Paediatric Research (ESPR)
• International Federation of Gynecology and Obstetrics (FIGO)
• Others

Public Domain Sources

• U.S. Food and Drug Administration (FDA)
• Centers for Disease Control and Prevention (CDC)
• National Institutes of Health (NIH)
• World Health Organization (WHO)
• UNICEF Data
• World Bank Open Data
• Eurostat
• Others

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of Information for the Last 10 Years